Enrico Rango

Via Aldo Moro 2
Siena, 53100, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications

Investigating the potential of the SI306 Src inhibitor and its liposomal formulation in the non-small cell lung cancer treatment.

Investigating the potential of the SI306 Src inhibitor and its liposomal formulation in the non-small cell lung cancer treatment.

Journal: International journal of pharmaceutics
Published: April 07, 2025

A pH-responsive crosslinker platform for antibody-drug conjugate (ADC) targeting delivery.

A pH-responsive crosslinker platform for antibody-drug conjugate (ADC) targeting delivery.

Journal: Chemical communications (Cambridge, England)
Published: August 31, 2022

The Pyrazolo[3,4-d]Pyrimidine Derivative Si306 Encapsulated into Anti-GD2-Immunoliposomes as Therapeutic Treatment of Neuroblastoma.

The Pyrazolo[3,4-d]Pyrimidine Derivative Si306 Encapsulated into Anti-GD2-Immunoliposomes as Therapeutic Treatment of Neuroblastoma.

Journal: Biomedicines
Published: February 14, 2022

Focused library of phenyl-fused macrocyclic amidinoureas as antifungal agents.

Focused library of phenyl-fused macrocyclic amidinoureas as antifungal agents.

Journal: Molecular diversity
Published: December 03, 2021

Antibacterial alkylguanidino ureas: Molecular simplification approach, searching for membrane-based MoA.

Antibacterial alkylguanidino ureas: Molecular simplification approach, searching for membrane-based MoA.

Journal: European journal of medicinal chemistry
Published: October 25, 2021

Bithiazole Inhibitors of Phosphatidylinositol 4-Kinase (PI4KIIIβ) as Broad-Spectrum Antivirals Blocking the Replication of SARS-CoV-2, Zika Virus, and Human Rhinoviruses.

Bithiazole Inhibitors of Phosphatidylinositol 4-Kinase (PI4KIIIβ) as Broad-Spectrum Antivirals Blocking the Replication of SARS-CoV-2, Zika Virus, and Human Rhinoviruses.

Journal: ChemMedChem
Published: July 09, 2021

Si113-prodrugs selectively activated by plasmin against hepatocellular and ovarian carcinoma.

Si113-prodrugs selectively activated by plasmin against hepatocellular and ovarian carcinoma.

Journal: European journal of medicinal chemistry
Published: March 18, 2021

AuNP Pyrazolo[3,4-d]pyrimidine Nanosystem in Combination with Radiotherapy against Glioblastoma.

AuNP Pyrazolo[3,4-d]pyrimidine Nanosystem in Combination with Radiotherapy against Glioblastoma.

Journal: ACS medicinal chemistry letters
Published: November 20, 2019

A New Strategy for Glioblastoma Treatment: In Vitro and In Vivo Preclinical Characterization of Si306, a Pyrazolo[3,4-d]Pyrimidine Dual Src/P-Glycoprotein Inhibitor.

A New Strategy for Glioblastoma Treatment: In Vitro and In Vivo Preclinical Characterization of Si306, a Pyrazolo[3,4-d]Pyrimidine Dual Src/P-Glycoprotein Inhibitor.

Journal: Cancers
Published: May 16, 2019
Showing 1-9 of 9

Last Updated: 09/26/2026